Skip to content

Clinical trials

Hodgkin Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Country / region: Australia Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20031
20041
20071
20082
20092
20101
20121
20183
20193
20225
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting5
Terminated4
Unknown status2
Active, not recruiting1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group6
Novartis Pharmaceuticals3
Bayside Health2
Merck Sharp & Dohme LLC2
Peter MacCallum Cancer Centre, Australia2
Seagen Inc.2
University College, London2
Accenture1
AstraZeneca1
Baxalta now part of Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease31
Lymphoma13
Lymphoma, Non-Hodgkin13
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Recurrence4
Burkitt Lymphoma3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, T-Cell, Cutaneous3
Lymphoma, T-Cell, Peripheral3

Trials

Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.